Related Experiment Video
Updated: Feb 13, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.4K
Patient barriers to insulin: The InfoCRIne order
1Department of Endocrinology, Bharti Hospital, Karnal, India.
JPMA. the Journal of the Pakistan Medical Association
|March 16, 2018
Summary
Insulin therapy initiation faces patient-level barriers in primary care. The InfoCRIne mnemonic and proposed strategies address hearsay, confidence, resources, and lifestyle concerns to improve insulin acceptance.
Area of Science:
- Endocrinology
- Primary Care Medicine
- Patient Adherence
Background:
- Insulin is a critical life-saving medication for diabetes management.
- Healthcare professionals face significant barriers to insulin use, particularly at the patient level.
- Patient resistance to injectable therapies is common in primary care settings.
Purpose of the Study:
- To identify key patient-level barriers to insulin initiation and acceptance.
- To propose practical strategies for overcoming these barriers in primary care.
- To introduce the InfoCRIne mnemonic as a framework for addressing insulin hesitancy.
Main Methods:
- Utilized the InfoCRIne mnemonic to categorize barriers to insulin therapy.
- Developed corresponding strategies ('bridges') to address each identified barrier.
- Focused on a practical and pragmatic approach for healthcare providers.
Main Results:
- Identified four primary barriers: hearsay, perceived inability to use insulin, perceived lack of resources, and intrusion into lifestyle.
- Proposed four corresponding strategies: information dissemination, confidence building, resource management, and individualization of treatment.
- Demonstrated the effectiveness of these strategies in overcoming patient resistance.
Conclusions:
- The InfoCRIne framework provides a systematic approach to initiating and accepting insulin therapy.
- Addressing patient-specific concerns is crucial for successful insulin adoption.
- Practical strategies can significantly improve patient adherence to insulin treatment in primary care.
Related Concept Videos
Insulin Secretory Vesicles
7.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.0K
Insulin: The Receptor and Signaling Pathways
3.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.5K
Insulin Formulations: Types and Delivery
794
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
794
Physiological Barriers
5.3K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.3K
Insulin: Biosynthesis, Chemistry, and Preparation
1.5K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.5K
Mucosal Barrier of the Stomach
2.5K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
2.5K

